Discover 419 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 419
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: Louisville KY, Columbus OH, Danville IL, Mattoon IL,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 60+
Code: NCT05976763
Phase3, Recruiting
Innovations in Personalizing Treatment Study
for
Eating Disorders
Location: Louisville KY
Sponsor: University of Louisville
Sex: All
Age: 18 - 65
Code: NCT06208605
Recruiting
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Location: Morehead KY, Muncie IN, Fort Wayne IN, Toledo OH,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06801834
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
for
Eosinophilic Asthma
Location: Louisville KY, Chattanooga TN, Toledo OH, Rock Hill SC,
Sponsor: Kymera Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07323654
Phase2, Recruiting
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
for
Limbal Stem Cell Deficiency
Location: Louisville KY, Carmel IN, Indianapolis IN, Smyrna TN,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 12 - 70+
Code: NCT07636590
Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for
Crohn's Disease
Location: Lexington KY, Cincinnati OH, Indianapolis IN,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06548542
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Lexington KY, Edgewood KY, Pittsburgh PA, Detroit MI,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06682988
Phase2, Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists